Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.
3.

The cost effectiveness of human papillomavirus vaccines: a systematic review.

Seto K, Marra F, Raymakers A, Marra CA.

Drugs. 2012 Mar 26;72(5):715-43. doi: 10.2165/11599470-000000000-00000. Review.

PMID:
22413761
4.

[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].

Westra TA, Daemen T, Postma MJ, Wilschut JC.

Ned Tijdschr Geneeskd. 2009;153:A356. Review. Dutch.

PMID:
19930733
5.

Modeling cervical cancer prevention in developed countries.

Kim JJ, Brisson M, Edmunds WJ, Goldie SJ.

Vaccine. 2008 Aug 19;26 Suppl 10:K76-86. doi: 10.1016/j.vaccine.2008.06.009. Review.

6.

Human papillomavirus vaccine: a paradigm shift for pediatricians.

Jenson HB.

Curr Opin Pediatr. 2009 Feb;21(1):112-21. doi: 10.1097/MOP.0b013e3283207f93. Review.

PMID:
19242247
7.

Economic evaluation of human papillomavirus vaccination in developed countries.

Brisson M, Van de Velde N, Boily MC.

Public Health Genomics. 2009;12(5-6):343-51. doi: 10.1159/000214924. Epub 2009 Aug 11. Review.

PMID:
19684446
8.

The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.

Setiawan D, Luttjeboer J, Westra TA, Wilschut JC, Suwantika AA, Daemen T, Atthobari J, Wilffert B, Postma MJ.

Expert Rev Vaccines. 2015 Apr;14(4):589-604. doi: 10.1586/14760584.2014.990386. Epub 2014 Dec 6. Review.

PMID:
25482311
9.

The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.

Holmes J, Hemmett L, Garfield S.

Eur J Health Econ. 2005 Mar;6(1):30-7. Review.

PMID:
15682286
10.

[Developments in HPV vaccination].

de Melker H, Kenter G, van Rossum T, Conyn-van Spaendonck M.

Ned Tijdschr Geneeskd. 2012;156(47):A5410. Review. Dutch.

PMID:
23171565
11.

Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.

Pharmacotherapy. 2011 Mar;31(3):280-97. doi: 10.1592/phco.31.3.280. Review.

PMID:
21361739
12.

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review.

Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G.

Pharmacoeconomics. 2009;27(2):127-47. doi: 10.2165/00019053-200927020-00004. Review. Erratum in: Pharmacoeconomics. 2009;27(4):354.

PMID:
19254046
13.

Quadrivalent human papillomavirus vaccine.

Barr E, Tamms G.

Clin Infect Dis. 2007 Sep 1;45(5):609-7. Epub 2007 Jul 25. Review.

14.

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review.

Fesenfeld M, Hutubessy R, Jit M.

Vaccine. 2013 Aug 20;31(37):3786-804. doi: 10.1016/j.vaccine.2013.06.060. Epub 2013 Jul 3. Review.

PMID:
23830973
15.

Cost-effectiveness analyses of human papillomavirus vaccination.

Newall AT, Beutels P, Wood JG, Edmunds WJ, MacIntyre CR.

Lancet Infect Dis. 2007 Apr;7(4):289-96. Review.

PMID:
17376386
16.

Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained.

Puig-Junoy J, Lopez-Valcarcel BG.

Prev Med. 2009 May;48(5):444-8. doi: 10.1016/j.ypmed.2009.02.011. Epub 2009 Feb 14. Review.

PMID:
19232368
17.

A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus.

Jiang Y, Gauthier A, Postma MJ, Ribassin-Majed L, Largeron N, Bresse X.

Hum Vaccin Immunother. 2013 Nov;9(11):2285-95. Epub 2013 Jul 23. Review.

18.

Modeling preventative strategies against human papillomavirus-related disease in developed countries.

Canfell K, Chesson H, Kulasingam SL, Berkhof J, Diaz M, Kim JJ.

Vaccine. 2012 Nov 20;30 Suppl 5:F157-67. doi: 10.1016/j.vaccine.2012.06.091. Review.

19.

Human papillomavirus vaccination in adolescence.

Russell M, Raheja V, Jaiyesimi R.

Perspect Public Health. 2013 Nov;133(6):320-4. doi: 10.1177/1757913913499091. Epub 2013 Sep 4. Review.

PMID:
24006173
20.

Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries.

Simonella L, Canfell K.

Vaccine. 2015 Jan 1;33(1):34-51. doi: 10.1016/j.vaccine.2014.08.048. Epub 2014 Aug 27. Review.

PMID:
25171843
Items per page

Supplemental Content

Write to the Help Desk